Dr. Michael Charlton is Chief of Hepatology, Director of the Center for Liver Diseases and Medical Director of the Transplant Institute at the University of Chicago. He is immediate Past President of the International Liver Transplant Society. Dr. Charlton previously served as Director of Hepatology and Medical Director of Liver Transplantation at Mayo Clinic in Rochester, Minnesota. He has held editorial roles for leading journals, including as an associate editor for Hepatology, Transplantation, American Journal of Transplantation, and Liver Transplantation, and was a founding Associate Editor for Clinical Gastroenterology and Hepatology.
He has served as principal investigator on grants from and been a study section member for the National Institutes of Health, including studies of the pathophysiology of nonalcoholic fatty liver disease. He has published over 200 manuscripts and is a lead investigator for national and international clinical trials in nonalcoholic steatohepatitis (NASH) and viral hepatitis. He serves as a panel member and writer of American Association for the Study of Liver Diseases (AASLD) Guidelines for the management of NASH and has also served as a panel member and writer of AASLD Guidelines for the management of HCV.